Increased risk of exotic mosquito-borne diseases with climate change

Could exotic mosquito-borne diseases emerge in Canada with climate change?

Download this article as a PDF
Published by: The Public Health Agency of Canada
Issue: Volume 45-4: Climate change and infectious diseases: The challenges
Date published: April 4, 2019
ISSN: 1481-8531

Subscribe to CCDR

Submit a manuscript

About CCDR

Browse

Past issues

Volume 45-4, April 4, 2019: Climate change and infectious diseases: The challenges

Overview

Could exotic mosquito-borne diseases emerge in Canada with climate change?

V Ng¹, EE Rees¹, RL Lindsay¹, MA Drebot¹, T Brownstone^1,2, T Sadeghieh^1,3, SU Khan^1,3

Affiliations

¹ National Microbiology Laboratory, Public Health Agency of Canada, Guelph, ON, St. Hyacinthe, QC and Winnipeg, MB

² Dalla Lana School of Public Health, University of Toronto, Toronto, ON

³ Department of Population Medicine, University of Guelph, Guelph, ON

Correspondence

victoria.ng@canada.ca

Suggested citation

Ng V, Rees EE, Lindsay LR, Drebot MA, Brownstone T, Sadeghieh T, Khan SU. Could exotic mosquito-borne diseases emerge in Canada with climate change? Can Commun Dis Rep 2019;45(4):98–107. https://doi.org/10.14745/ccdr.v45i04a04

Keywords: mosquito-borne disease, Canada, climate change, international travel, exotic vectors, Aedes albopictus, Culex mosquitoes, Anopheles species

Visual Abstract

Abstract

Of the 3,500 species of mosquitoes worldwide, only a small portion carry and transmit the mosquito-borne diseases (MBDs) that cause approximately half a million deaths annually worldwide. The most common exotic MBDs, such as malaria and dengue, are not currently established in Canada, in part because of our relatively harsh climate; however, this situation could evolve with climate change. Mosquitoes native to Canada may become infected with new pathogens and move into new regions within Canada. In addition, new mosquito species may move into Canada from other countries, and these exotic species may bring exotic MBDs as well. With high levels of international travel, including to locations with exotic MBDs, there will be more travel-acquired cases of MBDs. With climate change, there is the potential for exotic mosquito populations to become established in Canada. There is already a small area of Canada where exotic Aedes mosquitoes have become established although, to date, there is no evidence that these carry any exotic (or already endemic) MBDs. The increased risks of spreading MBDs, or introducing exotic MBDs, will need a careful clinical and public health response. Clinicians will need to maintain a high level of awareness of current trends, to promote mosquito bite prevention strategies, and to know the laboratory tests needed for early detection and when to report laboratory results to public health. Public health efforts will need to focus on ongoing active surveillance, public and professional awareness and mosquito control. Canadians need to be aware of the risks of acquiring exotic MBDs while travelling abroad as well as the risk that they could serve as a potential route of introduction for exotic MBDs into Canada when they return home.

Introduction

Mosquitoes cause approximately half a million deaths annually through the transmission of a range of mosquito-borne diseases (MBDs)^{Footnote 1}. The majority of MBDs, including malaria, dengue, chikungunya virus (CHIKV) and Zika virus (ZIKV), are transmitted to humans by mosquitoes that are not currently established in Canada^{Footnote 2}^{Footnote 3}^{Footnote 4}. Most of the important vectors are mosquitoes from the Aedes and Anopheles genera. These mosquitoes are exotic to Canada because our cooler climate and particularly our harsh winters, prevent these mosquitoes from becoming established here. In contrast, mosquitoes that are endemic to Canada, including Culex pipiens, Cx. restuans and Cx. tarsalis, which are the primary vectors for West Nile virus in Canada, can survive over winter by entering diapause and, in general, have lower developmental temperature thresholds than tropical/subtropical species^{Footnote 5}. Accordingly, MBDs transmitted by exotic mosquitoes are restricted to being acquired abroad, while MBDs transmitted by endemic mosquitoes are acquired both abroad and locally in Canada during the warmer months of the year^{Footnote 6}^{Footnote 7}^{Footnote 8}^{Footnote 9}^{Footnote 10}.

It is well known that MBDs are sensitive to climate, and that climatic conditions set the limits on the geography and seasonality of transmission; this is reflected in the distinct and often predictable seasonal distribution of MBDs^{Footnote 11}. A question that is often asked is: might climate change enable exotic MBDs to emerge and become established in Canada? The objectives of this paper are to identify the following: the exotic mosquitoes that carry pathogens causing human diseases; travel-acquired cases of exotic MBDs that have been reported in Canada; the climatic changes that could create local ecosystems in Canada that are conducive to the survival of exotic mosquitoes and the transmission of exotic MBDs; the potential routes of introduction of exotic MBDs into Canada as a result of climate change; and a summary of the clinical and public health implications.

Exotic mosquitoes that carry pathogens that cause human diseases

There are approximately 3,500 known species of mosquitoes worldwide, but only a small number can carry and transmit pathogens that cause illness in humans. The most prolific carriers and transmitters of exotic diseases to humans are Aedes genus mosquitoes. These mosquitoes, in particular Ae. aegypti and Ae. albopictus, have the potential to transmit over 20 pathogens that are infectious to humans including dengue, CHIKV, ZIKV and yellow fever^{Footnote 12}^{Footnote 13}. Aedes aegypti and Ae. albopictus are more widely distributed globally than any other mosquito species that are known to transmit diseases to humans^{Footnote 2}^{Footnote 3}. Collectively, their impact is far-reaching: between 1952 and 2017, the overall numbers of countries/territories reporting autochthonous mosquito-borne transmission of dengue, CHIKV, ZIKV and yellow fever were estimated to be 111, 106, 85 and 43, respectively^{Footnote 14}. The highly anthropophilic behaviour of Ae. aegypti and Ae. albopictus makes them two of the most medically-important mosquito species worldwide^{Footnote 15}.

The Anopheles genus of mosquitoes also carry and transmit pathogens that cause diseases of importance to humans; these include malaria and lymphatic filariasis (Table 1). Up to 41 Anopheles species have been identified as vectors for malaria^{Footnote 4}; three of these are co-carriers of parasites causing lymphatic filariasis^{Footnote 12}. Each vector has a distinct geographic dominance with multi-species coexistence, and distribution is generally worldwide across the tropics and subtropics^{Footnote 4}^{Footnote 16}. Globally, they are responsible for autochthonous malaria transmission in 87 countries, with a concentration of cases in Africa and India^{Footnote 17}. Concomitantly, over 70 countries in sub-Saharan Africa, Southeast Asia and the Pacific Islands report local lymphatic filariasis transmission^{Footnote 18}. Of the most common mosquitoes carrying diseases exotic to Canada, only two are established here (Table 1); An. freeborni and An. quadrimaculatus, the principal vectors for malaria. Additionally, Ae. albopictus, a principal vector for dengue, CHIKV, ZIKV and yellow fever, appears to have emerged and established in a very limited part of Southwestern Ontario in 2017^{Footnote 19}^{Footnote 20}. Other mosquitoes that carry diseases exotic to Canada include Culex and Mansonia species. Diseases that are carried by these mosquitoes include lymphatic filariasis, Japanese encephalitis, Rift Valley fever and Murray Valley encephalitis^{Footnote 12}.

Table 1: Common vectors of exotic mosquito-borne diseases in humans and the main diseases they carry
Mosquito genus	Mosquito species or species complex	Global distribution	Main disease/s carried	References
Aedes	Ae. aegypti	North and South America, Middle East, Africa, India/Western Asia and Southeast Asia and the Pacific	CHIKV, dengue, YF and ZIKV	^{Footnote 2}^{Footnote 3}^{Footnote 14}
	Ae. albopictus^{Footnote a of Table 1}	North and South America, Europe and Middle East, Africa, India/Western Asia and Southeast Asia and the Pacific	CHIKV, dengue and ZIKV (to a lesser degree than Ae. aegypti)	^{Footnote 2}^{Footnote 3}^{Footnote 14}^{Footnote 20}
	Ae. polynesiensis	South Pacific Islands	LF (W. bancrofti) and dengue	^{Footnote 12}
	Ae. scapularis	North and South America	LF (W. bancrofti)	^{Footnote 12}
	Ae. pseudoscutellaris	South Pacific Islands	LF (W. bancrofti) and dengue	^{Footnote 12}^{Footnote 21}^{Footnote 22}
Anopheles	An. albimanus, An. albitarsis, An. aquasalis, An. darlingi, An. freeborni^{Footnote b of Table 1}, An. marajoara, An. nuneztovari, An. pseudopunctipennis, An. quadrimaculatus^{Footnote b of Table 1}	North and South America	Malaria	^{Footnote 4}^{Footnote 19}
	An. atroparvus, An. labranchiae, An. messeae, An. sacharovi, An. sergentii, An. superpictus	Europe and Middle East	Malaria	^{Footnote 4}
	An. arabiensis, An. funestus^{Footnote c of Table 1}, An. gambiae^{Footnote c of Table 1}, An. melas, An. merus, An. moucheti, An. nili	Africa	Malaria Malaria and LF (W. bancrofti)^{Footnote c of Table 1}	^{Footnote 4}^{Footnote 12}^{Footnote 23}
	An. culicifacies, An. stephensi, An. fluviatilis	India/Western Asia	Malaria	^{Footnote 4}
	An. aconitus, An. annularis, An. balabacensis, An. barbirostris^{Footnote d of Table 1}, An. culicifacies, An. dirus, An. farauti, An. flavirostris, An. fluviatilis, An. koliensis, An. lesteri, An. leucosphyrus/latens, An. maculatus, An. minimus, An. punctulatus, An. sinensis, An. stephensi, An. subpictus, An. sundaicus	Southeast Asia and the Pacific	Malaria Malaria and LF (B. timori)^{Footnote d of Table 1}	^{Footnote 4}^{Footnote 12}
Culex	Cx. tritaeniorhychus	Southeast Asia and the Pacific, Africa, Middle East	JE, Rift Valley fever, Murray Valley encephalitis virus	^{Footnote 24}^{Footnote 25}
Culex	Cx. quinquefasciatus	North, Central and South America, Southeast Asia	LF (W. bancroft)	^{Footnote 12}^{Footnote 23}
Mansonia	Various species	Asia and the Pacific	LF (B. malayi)	^{Footnote 12}^{Footnote 23}
Abbreviations of Table 1 Abbreviations: Ae., Aedes; An., Anopheles; B., Brugia; CHIKV, chikungunya virus; Cx., Culex; JE, Japanese encephalitis; LF, lymphatic filariasis; W., Wuchereria; YF, yellow fever; ZIKV, Zika virus Footnote a of Table 1 Species that have recently established in Canada^{Footnote 20} Return to footnote a referrer of Table 1 Footnote b of Table 1 Species that are established in Canada^{Footnote 19} Return to first footnote b referrer of Table 1 Footnote c of Table 1 Species (An. funestus and An. gambiae) that transmit both malaria and LF (W. bancrofti) Return to first footnote c referrer of Table 1 Footnote d of Table 1 Species (An. barbirostris) that transmit both malaria and LF (B. timori) Return to first footnote d referrer of Table 1

Travel-acquired exotic mosquito-borne diseases

International travel is very common; approximately 4.75 million Canadian residents returned from abroad each month between 2014 and 2018; 3.77 million (82%) from the United States (US) and 985,000 (21%) from elsewhere^{Footnote 26}. The most common destinations outside of the USA are Mexico, Western Europe and the Caribbean (including Cuba, Dominican Republic and The Bahamas)^{Footnote 27}. It is, therefore, not surprising that Canadian residents often return with sporadic travel-acquired exotic MBDs; the most common being malaria and dengue^{Footnote 9}^{Footnote 28}^{Footnote 29}. Each year, approximately 500 cases of travel-acquired malaria are reported in returned travellers^{Footnote 30}. While dengue is not a notifiable disease in Canada, the National Microbiology Laboratory identified over 250 cases between 2012 and 2017, and a significant number of additional cases were documented by provincial public health laboratories in the same time period (unpublished data, Michael Drebot, National Microbiology Laboratory, Winnipeg, Canada). Dengue is currently considered one of the most critical MBDs worldwide and is of concern for Canadian residents given the 30-fold increase in global incidence over the past 50 years^{Footnote 31}^{Footnote 32}. The recent incursion of CHIKV and ZIKV into the western hemisphere and subsequent epidemic in the Caribbean and the Americas demonstrate the potential for exotic MBDs to spread extensively and rapidly across large vulnerable populations^{Footnote 33}^{Footnote 34}. As a result of the presence of MBDs worldwide, including in countries frequented by Canadian travellers, hundreds of residents returned to Canada with travel-acquired CHIKV and ZIKV between 2013 and 2017^{Footnote 7}^{Footnote 8}^{Footnote 10}^{Footnote 35}. Other common MBDs of concern for returned travellers include yellow fever, Japanese encephalitis and lymphatic filariasis. The recent outbreaks of yellow fever in Brazil and parts of Africa are a threat for Canadian residents travelling in those regions^{Footnote 36}^{Footnote 37}^{Footnote 38}, although confirmed cases in returned travellers remain low (14 cases between 2008 and 2016)^{Footnote 30} possibly due to the highly effective yellow fever vaccine recommended for Canadian travellers^{Footnote 39}^{Footnote 40}. The number of travel-acquired Japanese encephalitis and lymphatic filariasis cases is unknown as these diseases are not notifiable in Canada, but it is expected to be considerable given their high annual incidence globally^{Footnote 1}. Collectively, exotic MBDs result in thousands of travel-acquired infections annually in returned travellers.

Climate changes may create ecosystems for exotic mosquitoes

All parts of Canada are expected to experience climate change, but the impact will vary across regions, with the highest impact expected in the north^{Footnote 41}. A global warming of approximately 2°C is expected to bring milder temperatures, increased precipitation and humidity and more frequent extreme heat and precipitation events. As a result, winters are expected to be milder and shorter, while summers will be warmer and longer. A global warming of approximately 4°C is very likely to cause even greater changes, with extreme heat events, daily-scale precipitation extremes and a further increase in annual precipitation across most parts of Canada, but particularly in the north^{Footnote 41}. There are many ways in which these climate changes are expected to facilitate the emergence and transmission of exotic MBDs in Canada. Warmer temperature, higher humidity and increased precipitation will facilitate the lifecycle of exotic mosquitoes by supporting larval development and survival and extending adult lifespan, thus increasing overall population size^{Footnote 42}^{Footnote 43}^{Footnote 44}^{Footnote 45}. Climate change is also expected to influence disease transmission via several mechanisms:

Reducing egg development time in recently-fed adult female mosquitoes, thus reducing the time between blood meals and increasing feeding frequency^{Footnote 42}^{Footnote 43}^{Footnote 46}
Shortening the extrinsic incubation period, thereby allowing mosquitoes to become infectious faster^{Footnote 42}^{Footnote 43}^{Footnote 45}^{Footnote 46}^{Footnote 47}^{Footnote 48}
Increasing mosquito longevity, enabling infectious mosquitoes to bite more people^{Footnote 44}

As temperatures in Canada become milder and humidity and precipitation increase, larger parts of Canada will become climatically suitable for the establishment of some exotic mosquitoes that are currently limited to the tropics and subtropics^{Footnote 3}^{Footnote 49}^{Footnote 50}. Furthermore, as the winters become shorter and summers become longer, the duration of climatic suitability for disease transmission will increase, allowing autochthonous transmission of exotic MBDs for a limited period in some regions of Canada^{Footnote 49}. For exotic MBDs that are zoonoses and require an animal reservoir that is currently present in Canada (e.g. Japanese encephalitis), climate change could have further impact on the reservoir such as maintaining and supporting the expansion of natural habitats and prolonging the availability of food sources, thus increasing population size^{Footnote 51}^{Footnote 52}. Extreme weather events, such as droughts and heat events, can bring host reservoirs searching for water sources and mosquito breeding grounds together^{Footnote 53}^{Footnote 54}^{Footnote 55}.

Introduction of exotic mosquito-borne disease pathogens into Canada

For exotic MBD emergence, a competent mosquito vector, an appropriate reservoir host (if any) and the exotic pathogen must be brought together in a suitable habitat. While climate change can create additional habitats for mosquitoes and reservoir hosts, the pathogen needs to be introduced into Canada either via infected mosquitoes, viraemic humans and/or viraemic reservoirs^{Footnote 56}^{Footnote 57}. Pathogen introduction can occur either locally or globally.

Local introduction can occur during short-distance movement of mosquitoes/reservoirs/humans from a neighbouring endemic region into Canada. Exotic MBDs that may emerge through local introduction include Saint Louis encephalitis virus and La Crosse encephalitis virus because their vectors are already present in Canada and endemic in the US^{Footnote 58}^{Footnote 59}^{Footnote 60}. If climate change influences or leads to increased seasonal abundance and expansion of specific mosquito vectors (e.g. Ae. triseriatus), there is a higher risk for the spread of these pathogens to additional geographic regions in the country. Locally-acquired cases of exotic MBDs will likely emerge, with a high possibility of these diseases becoming endemic over time.

Global introduction can arise from long-distance movement (international travel, migration or trade/transportation of goods) of mosquitoes/reservoirs/humans from a distant endemic region into Canada. There are two global introduction scenarios in which vectors are either present or absent in Canada (Table 2). When the vector is present, climate change will likely increase travel-acquired cases of exotic MBDs by amplifying the natural transmission cycle and the likelihood of contact between vectors/reservoirs/humans in the country of origin, permit short-lived autochthonous transmission in Canada (as observed for CHIKV and ZIKV elsewhere)^{Footnote 61}^{Footnote 62}^{Footnote 63}^{Footnote 64}^{Footnote 65}^{Footnote 66} with the possibility of becoming endemic over time (as demonstrated by West Nile virus)^{Footnote 6}^{Footnote 67}^{Footnote 68}^{Footnote 69}. Diseases that may emerge under this scenario include malaria and CHIKV, because established or recently-emerged vector populations of these diseases are already present in Canada^{Footnote 19}^{Footnote 20}. When the vector is absent, and restrictions in the ecological niche of vectors may prevent establishment even with climate change, the impact of climate change will be limited to an increase in travel-acquired cases with no further local mosquito-borne transmission. While some types of global movement are linked to climate change [e.g. climate refugees^{Footnote 70} and changes in travel patterns^{Footnote 71}], many are not; however,global movement is increasing^{Footnote 72} and Canadians are avid travellers^{Footnote 26}, so even without the influence of climate change, global movement will continue to support emergence of exotic MBDs in Canada.

Table 2: Three routes of introduction of exotic mosquito-borne pathogens into Canada
Consideration	Local movement	Global movement, vector(s) present	Global movement, vector(s) absent
Emergence arising from local or global movement	Short-distance movement at the local scale	Long-distance movement at the global scale	Long-distance movement at the global scale
How geographic emergence may occur in Canada	Natural and regular movements of vectors/reservoirs/humans from a neighbouring endemic region	International travel, trade/transportation and migration of vectors/reservoirs/humans from a distant endemic region	International travel, trade/transportation and migration of vectors/reservoirs/humans from a distant endemic region
Pathogen	Present in a neighbouring endemic region (i.e., bordering a US state) but not in Canada	Present in a distant endemic region but not in Canada	Present in a distant endemic region but not in Canada
Vector mosquitoes present	Yes	Yes	No
Impact of climate change on emergence	Amplify the natural transmission cycle and increase the likelihood of contact between vectors/reservoirs/humans in Canada	Amplify the natural transmission cycle and increase the likelihood of contact between vectors/reservoirs/humans in Canada and in the country of origin Pathogen must be imported into Canada via infected mosquitoes or viraemic humans/reservoirs (driven primarily by global movement and partially by climate change)	Amplify the natural transmission cycle and increase the likelihood of contact between vectors/reservoirs/humans in Canada and in the country of origin Pathogen must be imported into Canada via infected mosquitoes or viraemic humans/reservoirs (driven primarily by global movement and partially by climate change)
Current disease presentation in Canada	Travel-acquired cases from the US	Travel-acquired cases from the US and globally	Travel-acquired cases from the US and globally
Diseases that may emerge in Canada with climate change	SLEV and LCEV virus via established Cx. tarsalis/pipiens/restuans (SLEV) and Ae. triseriatus (LCEV) populations^{Footnote 73}	CHIKV via the emergence of Ae.albopictus in Canada^{Footnote 20} or malaria via established An. freeborni and An. quadrimaculatus populations^{Footnote 19}	JE, Rift Valley fever and other exotic MBDs where a natural competent vector is not present in Canada (Table 1)
Anticipated disease emergence in Canada with climate change	Locally-acquired cases High possibility of becoming endemic over time	Increase in travel-acquired cases Autochthonous cases or short-lived autochthonous outbreaks transmitted by emerging or established vector populations Possibility of becoming endemic over time	Increase in travel-acquired cases, but no further local mosquito-borne transmission
Abbreviations of Table 2 Abbreviations: Ae., Aedes; An., Anopheles; CHIKV, chikungunya virus; Cx., Culex; JE, Japanese encephalitis; LCEV, La Crosse encephalitis virus; MBD, mosquito-borne disease; SLEV, Saint Louis encephalitis virus; US, United States

Clinical and public health implications

As climate change is anticipated to increase the risks for introduction of exotic MBDs into Canada and travel- and locally-acquired exotic MBDs in Canadian residents, vigilant clinical and public health response is essential. Clinicians should maintain a high level of awareness of current exotic MBD trends, promote mosquito bite prevention strategies by travellers, be aware of the laboratory tests needed for early detection and report notifiable diseases to public health. Public health professionals should focus on supporting ongoing active surveillance of exotic mosquitoes and pathogens, promoting public and professional awareness of exotic MBDs and mosquito control, including bite prevention. Canadian travellers need to be more aware of the risks that they could be acquiring exotic MBDs while travelling abroad as well as the risk that they could serve as a potential route of introduction for exotic MBDs into Canada. They can do this by seeking advice from local travel medicine clinics or by reviewing the travel health and safety sections of the government website (travel.gc.ca) prior to leaving the country.

Discussion

The most common travel-acquired exotic MBDs in Canada are malaria, dengue, CHIKV and ZIKV^{Footnote 7}^{Footnote 8}^{Footnote 9}^{Footnote 10}^{Footnote 28}^{Footnote 29}. Exotic mosquitoes that carry and transmit these diseases to humans are from the Anopheles and Aedes genera^{Footnote 12}. Currently, most of these mosquitoes are not present in Canada, but An. freeborni and An. quadrimaculatus (principal vectors for malaria) are widespread. Small numbers of Ae. aegypti and Ae. albopictus (principal vectors for dengue, CHIKV, ZIKV and yellow fever) have been introduced into parts of Canada and populations of the latter have recently established in a very limited region in Canada^{Footnote 19}^{Footnote 20}.

Climate change is expected to create and expand suitable habitats for exotic and endemic mosquitoes and their host reservoirs^{Footnote 3}^{Footnote 42}^{Footnote 50}^{Footnote 51}^{Footnote 52}^{Footnote 74}^{Footnote 75} and allow for establishment of exotic MBDs. Physiological changes in mosquitoes would increase their survival and ability to transmit diseases to humans^{Footnote 42}^{Footnote 43}^{Footnote 44}^{Footnote 45}^{Footnote 46}^{Footnote 47}^{Footnote 48}. In addition, lengthening the duration of climatic suitability for disease transmission^{Footnote 49}^{Footnote 76} could occur simultaneously both in Canada and in countries where exotic MBDs are already circulating. Climate change will also have an impact on the movement of vectors/reservoirs/humans and thus influence the introduction of exotic MBDs into Canada^{Footnote 70}^{Footnote 71}.

The relationship between climate and MBDs is not linear. For example, temperatures above a certain threshold may reduce mosquito survival or slow pathogen replication in mosquitoes^{Footnote 77}^{Footnote 78}. Thus, climate change can have an opposing effect on disease transmission such as supporting reservoir hosts while reducing pathogen and mosquito survival. There are other factors that will have a profound impact on exotic MBD emergence, including demographic changes (immigration and population growth)^{Footnote 79}^{Footnote 80}^{Footnote 81}^{Footnote 82}, increased mobility and interconnectivity^{Footnote 79}^{Footnote 80}^{Footnote 81}^{Footnote 83}, urbanization and land use^{Footnote 79}^{Footnote 80}^{Footnote 82}, and socioeconomic factors^{Footnote 79}^{Footnote 80}^{Footnote 81}^{Footnote 82}^{Footnote 84}^{Footnote 85}; and some of these factors will also be influenced by climate change.

While the short-term risk of exotic MBD incursion and establishment in Canada, facilitated or exacerbated by climate change, is very low^{Footnote 49}, it is feasible. The establishment of a new MBD has already been seen historically with West Nile virus^{Footnote 6}^{Footnote 67}^{Footnote 69}^{Footnote 86}^{Footnote 87}. Malaria is of particular concern given that it was once endemic in Canada^{Footnote 88}, a suspected autochthonous case was reported in 1996^{Footnote 89} and two dominant vectors are widespread in Canada^{Footnote 19}. Exotic MBDs transmitted by Ae. albopictus are also of concern, with the recent incursion of this species into temperate regions elsewhere that are climatically similar to parts of Canada^{Footnote 61}^{Footnote 64}^{Footnote 65}^{Footnote 90} and the emergence of one small region in Canada where Ae. albopictus appears to have become established^{Footnote 20}. Range expansion of this species within Canada will need to be monitored closely.

Conclusion

The exact impact of climate change on exotic MBD emergence in Canada is difficult to quantify but there are expected to be more travel-acquired cases, a higher potential for short-lived autochthonous outbreaks of exotic MBDs and a higher risk for exotic MBDs to become endemic, particularly if the vectors are already present in Canada. Overall, there is a risk of establishment of exotic mosquitoes and MBDs in Canada with climate change, especially those transmitted by Aedes albopictus mosquitoes. Some of these impacts can be mitigated by adopting clinical and public health measures, including promoting awareness and use of mosquito bite prevention strategies, early detection and prompt response, ongoing active surveillance and mosquito control. Canadians need to be aware of the exotic MBDs that they are at risk for while travelling abroad as disease risk will only increase with climate change. Further, Canadians returning home serve as a potential route of introduction for exotic MBDs, making the need for awareness even more urgent.

Authors’ statement

VN — Conceptualization, investigation, writing of original draft, supervision and project administration
EER — Writing: review and editing
LRL— Writing: review and editing
MAD — Writing: review and editing
TB — Investigation, writing: review and editing
TS — Investigation, writing: review and editing
SUK — Investigation, writing: review and editing

Conflict of interest

None.

Funding

This work was supported by the Public Health Agency of Canada.

References

Footnote 1

World Health Organization. Global vector control response 2017–2030. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. 2017. p. 64.

Return to first footnote 1 Referrer

Footnote 2

Kraemer MU, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, Messina JP, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel W, Hendrickx G, Schaffner F, Wint GR, Elyazar IR, Teng HJ, Hay SI. The global compendium of Aedes aegypti and Ae. albopictus occurrence. Sci Data 2015 Jul;2:150035. https://doi.org/10.1038/sdata.2015.35

Return to first footnote 2 Referrer

Footnote 3

Kamal M, Kenawy MA, Rady MH, Khaled AS, Samy AM. Mapping the global potential distributions of two arboviral vectors Aedes aegypti and Ae. albopictus under changing climate. PLoS One 2018 Dec;13(12):e0210122. https://doi.org/10.1371/journal.pone.0210122

Return to first footnote 3 Referrer

Footnote 4

Sinka ME, Bangs MJ, Manguin S, Rubio-Palis Y, Chareonviriyaphap T, Coetzee M, Mbogo CM, Hemingway J, Patil AP, Temperley WH, Gething PW, Kabaria CW, Burkot TR, Harbach RE, Hay SI. A global map of dominant malaria vectors. Parasit Vectors 2012 Apr;5(1):69. https://doi.org/10.1186/1756-3305-5-69

Return to first footnote 4 Referrer

Footnote 5

Madder DJ, Surgeoner GA, Helson BV. Induction of diapause in Culex pipiens and Culex restuans (Diptera: Culicidae) in southern Ontario. Can Entomol 1983;115(8):877–83. https://doi.org/10.4039/Ent115877-8

Return to footnote 5 Referrer

Footnote 6

Giordano BV, Kaur S, Hunter FF. West Nile virus in Ontario, Canada: A twelve-year analysis of human case prevalence, mosquito surveillance, and climate data. PLoS One 2017 Aug;12(8):e0183568. https://doi.org/10.1371/journal.pone.0183568

Return to first footnote 6 Referrer

Footnote 7

Tataryn J, Vrbova L, Drebot M, Wood H, Payne E, Connors S, Geduld J, German M, Khan K, Buck PA. Travel-related Zika virus cases in Canada: October 2015-June 2017. Can Commun Dis Rep 2018 Jan;44(1):18–26. https://doi.org/10.14745/ccdr.v44i01a05

Return to first footnote 7 Referrer

Footnote 8

Boggild AK, Geduld J, Libman M, Yansouni CP, McCarthy AE, Hajek J, Ghesquiere W, Mirzanejad Y, Vincelette J, Kuhn S, Plourde PJ, Chakrabarti S, Freedman DO, Kain KC. Surveillance report of Zika virus among Canadian travellers returning from the Americas. CMAJ 2017 Mar;189(9):E334–40. https://doi.org/10.1503/cmaj.161241

Return to first footnote 8 Referrer

Footnote 9

Boggild AK, Geduld J, Libman M, Yansouni CP, McCarthy AE, Hajek J, Ghesquiere W, Vincelette J, Kuhn S, Freedman DO, Kain KC. Malaria in travellers returning or migrating to Canada: surveillance report from CanTravNet surveillance data, 2004-2014. CMAJ Open 2016 Jul 6;4(3):E352–8. https://doi.org/10.9778/cmajo.20150115.

Return to first footnote 9 Referrer

Footnote 10

Drebot MA, Holloway K, Zheng H, Ogden NH. Travel-related chikungunya cases in Canada, 2014. Can Commun Dis Rep 2015 Jan;41(1):2–5. https://doi.org/10.14745/ccdr.v41i01a01

Return to first footnote 10 Referrer

Footnote 11

World Health Organization. Using climate to predict infectious disease epidemics. 2005, World Health Organisation: Geneva. p. 54.

Return to footnote 11 Referrer

Footnote 12

Edited by David L. Heymann. Control of Communicable Diseases Manual, 20th Edition. 20th ed. 2014: APHA Press. 729.

Return to first footnote 12 Referrer

Footnote 13

European Centre for Disease Control. Aedes albopictus - Factsheet for experts: Epidemiology and transmission of pathogens. 2016. https://ecdc.europa.eu/en/disease-vectors/facts/mosquito-factsheets/aedes-albopictus

Return to footnote 13 Referrer

Footnote 14

Leta S, Beyene TJ, De Clercq EM, Amenu K, Kraemer MU, Revie CW. Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus. Int J Infect Dis 2018 Feb;67:25–35. https://doi.org/10.1016/j.ijid.2017.11.026

Return to first footnote 14 Referrer

Footnote 15

Ponlawat A, Harrington LC. Blood feeding patterns of Aedes aegypti and Aedes albopictus in Thailand. J Med Entomol 2005 Sep;42(5):844–9. https://doi.org/10.1093/jmedent/42.5.844

Return to footnote 15 Referrer

Footnote 16

Kiszewski A, Mellinger A, Spielman A, Malaney P, Sachs SE, Sachs J. A global index representing the stability of malaria transmission. Am J Trop Med Hyg 2004 May;70(5):486–98. https://doi.org/10.4269/ajtmh.2004.70.486

Return to footnote 16 Referrer

Footnote 17

World Health Organization. World Malaria Report 2018. 2018, World Health Organization: Geneva.

Return to footnote 17 Referrer

Footnote 18

Cano J, Rebollo MP, Golding N, Pullan RL, Crellen T, Soler A, Kelly-Hope LA, Lindsay SW, Hay SI, Bockarie MJ, Brooker SJ. The global distribution and transmission limits of lymphatic filariasis: past and present. Parasit Vectors 2014 Oct;7(1):466. https://doi.org/10.1186/s13071-014-0466-x

Return to footnote 18 Referrer

Footnote 19

Berrang-Ford L, Maclean JD, Gyorkos TW, Ford JD, Ogden NH. Climate change and malaria in Canada: a systems approach. Interdiscip Perspect Infect Dis 2009;2009:385487. https://doi.org/10.1155/2009/385487

Return to first footnote 19 Referrer

Footnote 20

Windsor-Essex County Health Unit. Windsor-Essex County Health Unit - Aedes albopictus mosquito: 2018 adult mosquito survillance - Ae. albopictus mosquitoes identified. 2018. https://www.wechu.org/z-health-topics/aedes-albopictus-mosquito

Return to first footnote 20 Referrer

Footnote 21

Prakash G, Raju A, Koroivueta J. DF/DHF and Its Control in Fiji. 2001, World Health Organization. p. 21-27.

Return to footnote 21 Referrer

Footnote 22

Dutton TJ, Sinkins SP. Filarial susceptibility and effects of Wolbachia in Aedes pseudoscutellaris mosquitoes. Med Vet Entomol 2005 Mar;19(1):60–5. https://doi.org/10.1111/j.0269-283X.2005.00557.x

Return to footnote 22 Referrer

Footnote 23

Centres for Disease Control and Prevention. Vectors of Lymphatic Filariasis. 2018. https://www.cdc.gov/parasites/lymphaticfilariasis/gen_info/vectors.html

Return to first footnote 23 Referrer

Footnote 24

Longbottom J, Browne AJ, Pigott DM, Sinka ME, Golding N, Hay SI, Moyes CL, Shearer FM. Mapping the spatial distribution of the Japanese encephalitis vector, Culex tritaeniorhynchus Giles, 1901 (Diptera: Culicidae) within areas of Japanese encephalitis risk. Parasit Vectors 2017 Mar;10(1):148. https://doi.org/10.1186/s13071-017-2086-8

Return to footnote 24 Referrer

Footnote 25

Miller RH, Masuoka P, Klein TA, Kim HC, Somer T, Grieco J. Ecological niche modeling to estimate the distribution of Japanese encephalitis virus in Asia. PLoS Negl Trop Dis 2012;6(6):e1678. https://doi.org/10.1371/journal.pntd.0001678

Return to footnote 25 Referrer

Footnote 26

Statistics Canada. Table 24-10-0041-01 International travellers entering or returning to Canada, by type of transport. 2019. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=2410004101

Return to first footnote 26 Referrer

Footnote 27

Statistics Canada. Table 24-10-0037-01 Travel by Canadians to foreign countries, top 15 countries visited. 2019. https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=2410003701

Return to footnote 27 Referrer

Footnote 28

Boggild AK, Geduld J, Libman M, Ward BJ, McCarthy A, Hajek J, Ghesquiere W, Vincelette J, Kuhn S, Freedman DO, Kain KC. Travel-acquired infections in Canada: CanTravNet 2011-2012. Can Commun Dis Rep 2014 Sep;40(16):313–25. https://doi.org/10.14745/ccdr.v40i16a01

Return to first footnote 28 Referrer

Footnote 29

Boggild AK, Geduld J, Libman M, Ward BJ, McCarthy AE, Doyle PW, Ghesquiere W, Vincelette J, Kuhn S, Freedman DO, Kain KC. Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011. Open Med 2014 Feb;8(1):e20–32.

Return to first footnote 29 Referrer

Footnote 30

Government of Canada. Reported cases from 1924 to 2016 in Canada - Notifiable diseases on-line. 2019. http://diseases.canada.ca/notifiable/charts?c=pl

Return to first footnote 30 Referrer

Footnote 31

World Health Organization. Dengue Control. 2019. https://www.who.int/denguecontrol/disease/en/

Return to footnote 31 Referrer

Footnote 32

Ebi KL, Nealon J. Dengue in a changing climate. Environ Res 2016 Nov;151:115–23. https://doi.org/10.1016/j.envres.2016.07.026

Return to footnote 32 Referrer

Footnote 33

Pan American Health Organization. Chikungunya: Data, Maps and Statistics. 2017. https://www.paho.org/hq/index.php?option=com_topics&view=rdmore&cid=5927&item=chikungunya&type=statistics&Itemid=40931&lang=en

Return to footnote 33 Referrer

Footnote 34

Pan American Health Organization. Zika cases and congenital syndrome associated with Zika virus reported by countries and territories in the Americas, 2015-2018. Cumulative cases. 2018. https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=cumulative-cases-pdf-8865&alias=43296-zika-cumulative-cases-4-january-2018-296&Itemid=270&lang=en

Return to footnote 34 Referrer

Footnote 35

Ogden NH, Fazil A, Safronetz D, Drebot MA, Wallace J, Rees EE, Decock K, Ng V. Risk of travel-related cases of Zika virus infection is predicted by transmission intensity in outbreak-affected countries. Parasit Vectors 2017 Jan;10(1):41. https://doi.org/10.1186/s13071-017-1977-z

Return to footnote 35 Referrer

Footnote 36

Faria NR, Kraemer MU, Hill SC, Goes de Jesus J, Aguiar RS, Iani FC, Xavier J, Quick J, du Plessis L, Dellicour S, Thézé J, Carvalho RD, Baele G, Wu CH, Silveira PP, Arruda MB, Pereira MA, Pereira GC, Lourenço J, Obolski U, Abade L, Vasylyeva TI, Giovanetti M, Yi D, Weiss DJ, Wint GR, Shearer FM, Funk S, Nikolay B, Fonseca V, Adelino TE, Oliveira MA, Silva MV, Sacchetto L, Figueiredo PO, Rezende IM, Mello EM, Said RF, Santos DA, Ferraz ML, Brito MG, Santana LF, Menezes MT, Brindeiro RM, Tanuri A, Dos Santos FC, Cunha MS, Nogueira JS, Rocco IM, da Costa AC, Komninakis SC, Azevedo V, Chieppe AO, Araujo ES, Mendonça MC, Dos Santos CC, Dos Santos CD, Mares-Guia AM, Nogueira RM, Sequeira PC, Abreu RG, Garcia MH, Abreu AL, Okumoto O, Kroon EG, de Albuquerque CF, Lewandowski K, Pullan ST, Carroll M, de Oliveira T, Sabino EC, Souza RP, Suchard MA, Lemey P, Trindade GS, Drumond BP, Filippis AM, Loman NJ, Cauchemez S, Alcantara LC, Pybus OG. Genomic and epidemiological monitoring of yellow fever virus transmission potential. Science 2018 Aug;361(6405):894–9. https://doi.org/10.1126/science.aat7115

Return to footnote 36 Referrer

Footnote 37

Possas C, Lourenço-de-Oliveira R, Tauil PL, Pinheiro FP, Pissinatti A, Cunha RV, Freire M, Martins RM, Homma A. Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation. Mem Inst Oswaldo Cruz 2018 Sep;113(10):e180278. https://doi.org/10.1590/0074-02760180278

Return to footnote 37 Referrer

Footnote 38

Kwagonza L, Masiira B, Kyobe-Bosa H, Kadobera D, Atuheire EB, Lubwama B, Kagirita A, Katushabe E, Kayiwa JT, Lutwama JJ, Ojwang JC, Makumbi I, Ario AR, Borchert J, Zhu BP. Outbreak of yellow fever in central and southwestern Uganda, February-may 2016. BMC Infect Dis 2018 Nov;18(1):548. https://doi.org/10.1186/s12879-018-3440-y

Return to footnote 38 Referrer

Footnote 39

Ahuka-Mundeke S, Casey RM, Harris JB, Dixon MG, Nsele PM, Kizito GM, Umutesi G, Laven J, Paluku G, Gueye AS, Hyde TB, Sheria GK, Muyembe-Tanfum JJ, Staples JE. Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report. N Engl J Med 2018 Feb. https://doi.org/10.1056/NEJMoa1710430

Return to footnote 39 Referrer

Footnote 40

Gotuzzo E, Yactayo S, Córdova E. Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. Am J Trop Med Hyg 2013 Sep;89(3):434–44. https://doi.org/10.4269/ajtmh.13-0264

Return to footnote 40 Referrer

Footnote 41

Romero-Lankao P, Smith J, Davidson D, Diffenbaugh N, Kinney P, Kirshen P, Kovacs P, Villers Ruiz L. North America. In: Climate Change 2014: Impacts, Adaptation, and Vulnerability. Part B: Regional Aspects. Contribution of Working Group II to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change [Barros, V.R., C.B. Field, D.J. Dokken, M.D. Mastrandrea, K.J. Mach, T.E. Bilir, M. Chatterjee, K.L. Ebi, Y.O. Estrada, R.C. Genova, B. Girma, E.S. Kissel, A.N. Levy, S. MacCracken, P.R. Mastrandrea, and L.L. White (eds.)]. 2014: Cambridge University Press, Cambridge, United Kingdom and New York, NY, USA. p. 1439-1498.

Return to first footnote 41 Referrer

Footnote 42

Jetten TH, Focks DA. Potential changes in the distribution of dengue transmission under climate warming. Am J Trop Med Hyg 1997 Sep;57(3):285–97. https://doi.org/10.4269/ajtmh.1997.57.285

Return to first footnote 42 Referrer

Footnote 43

Reeves WC, Hardy JL, Reisen WK, Milby MM. Potential effect of global warming on mosquito-borne arboviruses. J Med Entomol 1994 May;31(3):323–32. https://doi.org/10.1093/jmedent/31.3.323

Return to first footnote 43 Referrer

Footnote 44

Yang HM, Macoris ML, Galvani KC, Andrighetti MT, Wanderley DM. Assessing the effects of temperature on the population of Aedes aegypti, the vector of dengue. Epidemiol Infect 2009 Aug;137(8):1188–202. https://doi.org/10.1017/S0950268809002040

Return to first footnote 44 Referrer

Footnote 45

Paaijmans KP, Read AF, Thomas MB. Understanding the link between malaria risk and climate. Proc Natl Acad Sci USA 2009 Aug;106(33):13844–9. https://doi.org/10.1073/pnas.0903423106

Return to first footnote 45 Referrer

Footnote 46

Paaijmans KP, Cator LJ, Thomas MB. Temperature-dependent pre-bloodmeal period and temperature-driven asynchrony between parasite development and mosquito biting rate reduce malaria transmission intensity. PLoS One 2013;8(1):e55777. https://doi.org/10.1371/journal.pone.0055777

Return to first footnote 46 Referrer

Footnote 47

Davis NC. The effect of various temperatures in modifying the extrinsic incubation period of the yellow fever virus in Aedes aegypti*. Am J Epidemiol 1932;16(1):163–76. https://doi.org/10.1093/oxfordjournals.aje.a117853

Return to first footnote 47 Referrer

Footnote 48

Xiao FZ, Zhang Y, Deng YQ, He S, Xie HG, Zhou XN, Yan YS. The effect of temperature on the extrinsic incubation period and infection rate of dengue virus serotype 2 infection in Aedes albopictus. Arch Virol 2014 Nov;159(11):3053–7. https://doi.org/10.1007/s00705-014-2051-1

Return to first footnote 48 Referrer

Footnote 49

Ng V, Fazil A, Gachon P, Deuymes G, Radojević M, Mascarenhas M, Garasia S, Johansson MA, Ogden NH. Assessment of the Probability of Autochthonous Transmission of Chikungunya Virus in Canada under Recent and Projected Climate Change. Environ Health Perspect 2017 Jun;125(6):067001. https://doi.org/10.1289/EHP669

Return to first footnote 49 Referrer

Footnote 50

Ogden NH, Milka R, Caminade C, Gachon P. Recent and projected future climatic suitability of North America for the Asian tiger mosquito Aedes albopictus. Parasit Vectors 2014 Dec;7:532. https://doi.org/10.1186/s13071-014-0532-4

Return to first footnote 50 Referrer

Footnote 51

Clement J, Vercauteren J, Verstraeten WW, Ducoffre G, Barrios JM, Vandamme AM, Maes P, Van Ranst M. Relating increasing hantavirus incidences to the changing climate: the mast connection. Int J Health Geogr 2009 Jan;8:1. https://doi.org/10.1186/1476-072X-8-1

Return to first footnote 51 Referrer

Footnote 52

Ng V, Dear K, Harley D, McMichael A. Analysis and prediction of Ross River virus transmission in New South Wales, Australia. Vector Borne Zoonotic Dis 2014 Jun;14(6):422–38. https://doi.org/10.1089/vbz.2012.1284

Return to first footnote 52 Referrer

Footnote 53

Harrigan RJ, Thomassen HA, Buermann W, Smith TB. A continental risk assessment of West Nile virus under climate change. Glob Change Biol 2014 Aug;20(8):2417–25. https://doi.org/10.1111/gcb.12534

Return to footnote 53 Referrer

Footnote 54

Shaman J, Day JF, Stieglitz M. Drought-induced amplification and epidemic transmission of West Nile virus in southern Florida. J Med Entomol 2005 Mar;42(2):134–41. https://doi.org/10.1093/jmedent/42.2.134

Return to footnote 54 Referrer

Footnote 55

Wang G, Minnis RB, Belant JL, Wax CL. Dry weather induces outbreaks of human West Nile virus infections. BMC Infect Dis 2010 Feb;10:38. https://doi.org/10.1186/1471-2334-10-38

Return to footnote 55 Referrer

Footnote 56

Giladi M, Metzkor-Cotter E, Martin DA, Siegman-Igra Y, Korczyn AD, Rosso R, Berger SA, Campbell GL, Lanciotti RS. West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis 2001 Jul-Aug;7(4):659–61. https://doi.org/10.3201/eid0704.017410

Return to footnote 56 Referrer

Footnote 57

Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret JH, Hall RA, MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, Malkinson M, Banet C, Weissman J, Komar N, Savage HM, Stone W, McNamara T, Gubler DJ. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999 Dec;286(5448):2333–7. https://doi.org/10.1126/science.286.5448.2333

Return to footnote 57 Referrer

Footnote 58

Giordano BV, Gasparotto A, Hunter FF. A checklist of the 67 mosquito species of Ontario, Canada. J Am Mosq Control Assoc 2015 Mar;31(1):101–3. https://doi.org/10.2987/14-6456R.1

Return to footnote 58 Referrer

Footnote 59

Centres for Disease Control and Prevention. Saint Louis encephalitis: Epidemiology and Geographic Distribution. 2018 November 2, 2018]; https://www.cdc.gov/sle/technical/epi.html

Return to footnote 59 Referrer

Footnote 60

Centres for Disease Control and Prevention. La Crosse encephalitis: Epidemiology and Geographic Distribution. 2018. https://www.cdc.gov/lac/tech/epi.html

Return to footnote 60 Referrer

Footnote 61

Venturi G, Di Luca M, Fortuna C, Remoli ME, Riccardo F, Severini F, Toma L, Del Manso M, Benedetti E, Caporali MG, Amendola A, Fiorentini C, De Liberato C, Giammattei R, Romi R, Pezzotti P, Rezza G, Rizzo C. Detection of a chikungunya outbreak in Central Italy, August to September 2017. Euro Surveill 2017 Sep;22(39):17–00646. https://doi.org/10.2807/1560-7917.ES.2017.22.39.17-00646

Return to first footnote 61 Referrer

Footnote 62

Septfons A, Leparc-Goffart I, Couturier E, Franke F, Deniau J, Balestier A, Guinard A, Heuzé G, Liebert AH, Mailles A, Ndong JR, Poujol I, Raguet S, Rousseau C, Saidouni-Oulebsir A, Six C, Subiros M, Servas V, Terrien E, Tillaut H, Viriot D, Watrin M, Wyndels K, Noel H, Paty MC, De Valk H; Zika Surveillance Working Group in French departments and collectivities of the Americas. Travel-associated and autochthonous Zika virus infection in mainland France, 1 January to 15 July 2016. Euro Surveill 2016 Aug;21(32). https://doi.org/10.2807/1560-7917.ES.2016.21.32.30315

Return to footnote 62 Referrer

Footnote 63

Likos A, Griffin I, Bingham AM, Stanek D, Fischer M, White S, Hamilton J, Eisenstein L, Atrubin D, Mulay P, Scott B, Jenkins P, Fernandez D, Rico E, Gillis L, Jean R, Cone M, Blackmore C, McAllister J, Vasquez C, Rivera L, Philip C. Local Mosquito-Borne Transmission of Zika Virus - Miami-Dade and Broward Counties, Florida, June-August 2016. MMWR Morb Mortal Wkly Rep 2016 Sep;65(38):1032–8. https://doi.org/10.15585/mmwr.mm6538e1

Return to footnote 63 Referrer

Footnote 64

Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A; CHIKV study group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007 Dec;370(9602):1840–6. https://doi.org/10.1016/S0140-6736(07)61779-6

Return to first footnote 64 Referrer

Footnote 65

Delisle E, Rousseau C, Broche B, Leparc-Goffart I, L’Ambert G, Cochet A, Prat C, Foulongne V, Ferre JB, Catelinois O, Flusin O, Tchernonog E, Moussion IE, Wiegandt A, Septfons A, Mendy A, Moyano MB, Laporte L, Maurel J, Jourdain F, Reynes J, Paty MC, Golliot F. Chikungunya outbreak in Montpellier, France, September to October 2014. Euro Surveill 2015 Apr;20(17):21108. https://doi.org/10.2807/1560-7917.ES2015.20.17.21108

Return to first footnote 65 Referrer

Footnote 66

Bouri N, Sell TK, Franco C, Adalja AA, Henderson DA, Hynes NA. Return of epidemic dengue in the United States: implications for the public health practitioner. Public Health Rep 2012 May-Jun;127(3):259–66. https://doi.org/10.1177/003335491212700305

Return to footnote 66 Referrer

Footnote 67

Artsob H, Gubler DJ, Enria DA, Morales MA, Pupo M, Bunning ML, Dudley JP. West Nile Virus in the New World: trends in the spread and proliferation of West Nile Virus in the Western Hemisphere. Zoonoses Public Health 2009 Aug;56(6)(7):357–69. https://doi.org/10.1111/j.1863-2378.2008.01207.x

Return to first footnote 67 Referrer

Footnote 68

Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007 Oct;45(8):1039–46. https://doi.org/10.1086/521911

Return to footnote 68 Referrer

Footnote 69

Zheng H, Drebot MA, Coulthart MB. West Nile virus in Canada: ever-changing, but here to stay. Can Commun Dis Rep 2014 May;40(10):173–7. https://doi.org/10.14745/ccdr.v40i10a01

Return to first footnote 69 Referrer

Footnote 70

McMichael C, Barnett J, McMichael AJ. An ill wind? Climate change, migration, and health. Environ Health Perspect 2012 May;120(5):646–54. https://doi.org/10.1289/ehp.1104375

Return to first footnote 70 Referrer

Footnote 71

World Tourism Organization and United Nations Environment Programme. Climate Change and Tourism - Responding to Global Challenges. 2008, World Tourism Organization: Madrid, Spain. p. 269.

Return to first footnote 71 Referrer

Footnote 72

Findlater A, Bogoch II. Human Mobility and the Global Spread of Infectious Diseases: A Focus on Air Travel. Trends Parasitol 2018 Sep;34(9):772–83. https://doi.org/10.1016/j.pt.2018.07.004

Return to footnote 72 Referrer

Footnote 73

Giordano BV, Turner KW, Hunter FF. Geospatial Analysis and Seasonal Distribution of West Nile Virus Vectors (Diptera: Culicidae) in Southern Ontario, Canada. Int J Environ Res Public Health 2018 Mar;15(4):E614. https://doi.org/10.3390/ijerph15040614

Return to footnote 73 Referrer

Footnote 74

Ogden NH. Climate change and vector-borne diseases of public health significance. FEMS Microbiol Lett 2017 Oct;364(19). https://doi.org/10.1093/femsle/fnx186

Return to footnote 74 Referrer

Footnote 75

Rochlin I, Ninivaggi DV, Hutchinson ML, Farajollahi A. Climate change and range expansion of the Asian tiger mosquito (Aedes albopictus) in Northeastern USA: implications for public health practitioners. PLoS One 2013;8(4):e60874. https://doi.org/10.1371/journal.pone.0060874

Return to footnote 75 Referrer

Footnote 76

Fischer D, Thomas SM, Suk JE, Sudre B, Hess A, Tjaden NB, Beierkuhnlein C, Semenza JC. Climate change effects on Chikungunya transmission in Europe: geospatial analysis of vector’s climatic suitability and virus’ temperature requirements. Int J Health Geogr 2013 Nov;12:51. https://doi.org/10.1186/1476-072X-12-51

Return to footnote 76 Referrer

Footnote 77

Reisen WK. Effect of temperature on Culex tarsalis (Diptera: Culicidae) from the Coachella and San Joaquin Valleys of California. J Med Entomol 1995 Sep;32(5):636–45. https://doi.org/10.1093/jmedent/32.5.636

Return to footnote 77 Referrer

Footnote 78

Reisen WK, Fang Y, Martinez VM. Effects of temperature on the transmission of west nile virus by Culex tarsalis (Diptera: culicidae). J Med Entomol 2006 Mar;43(2):309–17. https://doi.org/10.1093/jmedent/43.2.309

Return to footnote 78 Referrer

Footnote 79

Kilpatrick AM, Randolph SE. Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. Lancet 2012 Dec;380(9857):1946–55. https://doi.org/10.1016/S0140-6736(12)61151-9

Return to first footnote 79 Referrer

Footnote 80

Romeo-Aznar V, Paul R, Telle O, Pascual M. Mosquito-borne transmission in urban landscapes: the missing link between vector abundance and human density. Proc Biol Sci 2018 Aug;285(1884). https://doi.org/10.1098/rspb.2018.0826

Return to first footnote 80 Referrer

Footnote 81

Lindsey NP, Staples JE, Fischer M. Chikungunya Virus Disease among Travelers-United States, 2014-2016. Am J Trop Med Hyg 2018 Jan;98(1):192–7. https://doi.org/10.4269/ajtmh.17-0668

Return to first footnote 81 Referrer

Footnote 82

Jones B, O’Neill B. Spatially explicit global population scenarios consistent with the Shared Socioeconomic Pathways. Environ Res Lett 2016;11(084003). https://doi.org/10.1088/1748-9326/11/8/084003

Return to first footnote 82 Referrer

Footnote 83

Tatem AJ, Hay SI, Rogers DJ. Global traffic and disease vector dispersal. Proc Natl Acad Sci USA 2006 Apr;103(16):6242–7. https://doi.org/10.1073/pnas.0508391103

Return to footnote 83 Referrer

Footnote 84

Kc S, Lutz W. The human core of the shared socioeconomic pathways: population scenarios by age, sex and level of education for all countries to 2100. Glob Environ Change 2017 Jan;42:181–92. https://doi.org/10.1016/j.gloenvcha.2014.06.004

Return to footnote 84 Referrer

Footnote 85

Moreno-Madriñán MJ, Turell M. History of Mosquitoborne Diseases in the United States and Implications for New Pathogens. Emerg Infect Dis 2018 May;24(5):821–6. https://doi.org/10.3201/eid2405.171609

Return to footnote 85 Referrer

Footnote 86

Paz S. Climate change impacts on West Nile virus transmission in a global context. Philos Trans R Soc Lond B Biol Sci 2015 Apr;370(1665):20130561. https://doi.org/10.1098/rstb.2013.0561

Return to footnote 86 Referrer

Footnote 87

Reisen WK. Ecology of West Nile virus in North America. Viruses 2013 Sep;5(9):2079–105. https://doi.org/10.3390/v5092079

Return to footnote 87 Referrer

Footnote 88

Fallis AM. Malaria in the 18th and 19th centuries in Ontario. Bull Can Hist Med 1984;1(2):25–38. https://doi.org/10.3138/cbmh.1.2.25

Return to footnote 88 Referrer

Footnote 89

Baqi M, Gamble K, Keystone JS, Kain KC. Malaria: Probably locally acquired in Toronto, Ontario. Can J Infect Dis 1998 May;9(3):183–4. https://doi.org/10.1155/1998/150650

Return to footnote 89 Referrer

Footnote 90

Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noël H, De Lamballerie X, Paty MC, Leparc-Goffart I. Preliminary report of an autochthonous chikungunya outbreak in France, July to September 2017. Euro Surveill 2017 Sep;22(39). https://doi.org/10.2807/1560-7917.ES.2017.22.39.17-00647

Return to footnote 90 Referrer

This work is licensed under a Creative Commons Attribution 4.0 International License

Table of contents

Page details

Date modified:: 2019-10-25

Language selection

Search